Neurology Neurodiagnostic Lab — Alabaster, Alabama

Neurology Neurodiagnostic Lab is a clinical research site located in Alabaster, Alabama, United States 35007.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Neurology Neurodiagnostic Lab has participated in 2 clinical trials.

Therapeutic areas: Orthostatic Hypotension, Parkinson's Disease, Mild Cognitive Impairment.

Sponsors: Chelsea Therapeutics, Eisai Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Alabaster

Browse all research sites in Alabama · View every site in Alabaster

• GSK Investigational Site
• Research Site
• Alabama Kidney Research
• Wright Clinical Research
• Pfizer Investigational Site
• 786
• Investigational Site
• Novo Nordisk Investigational Site
• Alabama Oncology
• Heart South Cardiovascular Group PC
• Carol M. Johnson MD, LLC

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Neurology Neurodiagnostic Lab?

Neurology Neurodiagnostic Lab has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Neurology Neurodiagnostic Lab conducted?

Neurology Neurodiagnostic Lab has 2 clinical trials on record. Their work covers Orthostatic Hypotension, Parkinson's Disease, Mild Cognitive Impairment.

Is Neurology Neurodiagnostic Lab accredited by Crixeo Clinical Trials?

Neurology Neurodiagnostic Lab has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Neurology Neurodiagnostic Lab?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.